Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Intractable Abdominal Pain in the ED
NCT07826936Phase 1Recruiting
- Sponsor
- University of California, Irvine
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of bupivacaine in abdominal pain (2 arms), sponsored by University of California, Irvine. Primary endpoint: Change in Pain Score at 3 hours. Started Oct 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
abdominal pain
Beyond the preview
Go deeper on NCT07826936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826936.